CorMedix (CRMD) Revenue (QoQ) (2015 - 2025)
CorMedix (CRMD) Revenue (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
23.34% |
| Sep 30, 2025 |
162.41% |
| Jun 30, 2025 |
1.68% |
| Mar 31, 2025 |
25.22% |
| Dec 31, 2024 |
172.43% |
| Sep 30, 2024 |
1,321.14% |
| Dec 31, 2022 |
335.70% |
| Sep 30, 2022 |
-67.92% |
| Jun 30, 2022 |
178.33% |
| Mar 31, 2022 |
-86.46% |
| Dec 31, 2021 |
48.07% |
| Sep 30, 2021 |
365.00% |
| Jun 30, 2021 |
-90.72% |
| Mar 31, 2021 |
58.42% |
| Dec 31, 2020 |
-40.11% |
| Sep 30, 2020 |
465.71% |
| Jun 30, 2020 |
-77.80% |
| Mar 31, 2020 |
198.87% |
| Dec 31, 2019 |
-58.38% |
| Sep 30, 2019 |
68.80% |
